|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| C07K 16/28 | (2006.01) | ||
| A61M 5/315 | (2006.01) |
| (11) | Number of the document | 2624865 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11770625.9 |
| Date of filing the European patent application | 2011-10-05 | |
| (97) | Date of publication of the European application | 2013-08-14 |
| (45) | Date of publication and mention of the grant of the patent | 2018-08-01 |
| (46) | Date of publication of the claims translation | 2018-10-25 |
| (86) | Number | PCT/US2011/054856 |
| Date | 2011-10-05 |
| (87) | Number | WO 2012/047954 |
| Date | 2012-04-12 |
| (30) | Number | Date | Country code |
| 390283 P | 2010-10-06 | US |
| (72) |
DIX, Daniel, B., US
TANG, Xiaolin, US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Stabilizuotos kompozicijos turinčios savo sudėtyje antikūnus prieš interleukino 4 receptorių (IL-4R) |
| STABILIZED FORMULATIONS CONTAINING ANTI-INTERLEUKIN-4 RECEPTOR (IL-4R) ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2025-09-23 | 15 | 289.00 EUR |
| 2026-10-05 |